Featured series 
Tag: Joseph Paul Eder
-
Health
Endostatin shows no toxicity and some clinical activity in latest report on phase I trial
Discovered in the Children’s Hospital Boston laboratory of Judah Folkman, Endostatin is a natural substance that blocks the formation of new blood vessels around and in tumors, thereby disrupting their ability to survive and grow. The formation of new blood vessels, a process called angiogenesis, can be helpful — in wound healing, for example —…
-
Health
Researchers see better treatments for cancer
“Before the development of insulin, diabetes was as deadly as many cancers are today,” says Harvard researcher Joseph Paul Eder, who is testing Endostatin on patients with advanced cancers. “In a couple of decades, people may be able to live 30 to 40 years, or more, after being diagnosed with breast, prostate, or other cancers.”…